Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Bully88on Mar 17, 2021 10:34am
115 Views
Post# 32815894

RE:RE:RE:RE:RE:RE:ARISTOTLE....

RE:RE:RE:RE:RE:RE:ARISTOTLE....
Skrit37 wrote:
MarketMoney wrote:
Skrit37 wrote:
MarketMoney wrote:

 

molotov420 wrote: I am getting concerned....only 10 trading days left this quarter. Why wait till the last day? IR team says its on track. God I hope they arent screwin with me

 

 

Why would you be concern for 10 trading days left to this quarter?
 

Why would SZLS put on SEDAR an early record and vote date set at March 29th if there would be concern about the launch? SZLS didn't set any early record and vote date for the AGM for years!

 



For those of us that have been here a long time....forgive our impatience as the hour gets closer....this ain't our first rodeo....... Fingers are crossed ......... Goodluck folks


 

 

Yes and I understand your situation, for almost 5 years the shareprice was trading under the weekly EMA(30)...so for 5 years wasn't the best time to invest.....now the shareprice is trading above a confortable weekly EMA(30) and finaly you have a weekly stage 2, now is not the moment to stress but to enjoy what SZLS as achieved. 



I dunno...fortunately I purchased all my shares when the stock was near its low...happy I didn't look at any ema lines..else I wouldn't be way in the green...... ..its the product that matters....the stockpice will follow occordingly.......I do enjoy reading your analysis though ...so don't get me wrong ....not trying to argue...just discussing different view point haha



I see both sides of the Debate. i believe that marketmoney is fair in his technical analysis and how it is supply and demand , but at the same time i believe others are fair in saying that this news coming up will have a big impact on that supply and demand.

in my own opinion, i feel there is only a limited demand until aristotle is released.

J sweezy Tripp Teezy has stated multiple times We are ready for a go Q1.  So as they have been very Prompt on their word as of recently in their latest prospectus', I feel they will continue.

If we launch during the timeline they have given us, that will create alot of demand, and ALOT of shares that are being held by Longs and institutions and insiders that the supply will be limited. then we technically ANALyse it to the moon!

If they do not deliver as per their timeline, it will hurt the demand and have a more open supply as many people dont like that kind of missing timelines  lower reliability in a company. we are then the ones being ANALysed

add in the fact that many people who are holding are in a very positive ROI and could look to pull some off the table until they get more information of an official launch.

SImple terms,

bad news = low demand high supply  = price goes down
good news = high demand low supply = price goes up

We are currently still making rediculous amounts of cash in an unforseen market of covid testing. still no end in sight with these new variations, opening up too soon. etc..

The Covid revenue is a solid source of revenue  but does have an exiration date. That in my opinion in adition to being pre aristotle, is what has brought our share price to where they are today.

yes there can be some short term tehnical plays here which we all appreciate the insight too as it adds more in depth look at day trading and the stock in general.

But as a more long term trader i remain strong on the opinion that releasing aristotle is the catalyst we need to take it to the next step driving massive demand, as expected by massive revenue possibilities with the real Holy Grail of Cancer testing

i also remain strong opinion that this is a  lose 50% before you can pull out, or gain 100s of % to 1000s of % ROI.

Tick Tock.  

Were lmost there,

Hold strong with Diamond hands you sick F*cks

When this thing launches,

To the Moon

Cheers,

Bully






<< Previous
Bullboard Posts
Next >>